Redsewey was approved in Australia.
-
Last Update: 2020-07-22
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On July 10, the Australian Medical Supplies Authority (TGA) provisionally approved the listing of Gilead's Veklury (Redseywe) for severe hospitalization of COVID-19 adults and adolescentsthis is the first COVID-19 treatment approved in AustraliaRedsewe is currently on the market in the US, the European Union and Japan, and its generics have been approved in IndiaRedsewe is priced at $390 a dose in developed countries, and a course of treatment (six doses over five days) costs about $3,120Reedsivir generics, made by Indian pharmaceutical company Cipla, are priced at 4,000 rupees ($53) per dose.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.